Read + Share
Kaul I, Claxton A, Chaturvedi S, Patel T, et al. Long-term efficacy, safety, and tolerability of xanomeline and trospium chloride
in schizophrenia: A 52-week, open-label trial (EMERGENT-5). Schizophr Res 2026;288:86-94.
PMID: 41506001
|
 |
|
Kaul I, Claxton A, Chaturvedi S, Patel T, et al. Long-term efficacy, safety, and tolerability of xanomeline and trospium chloride
in schizophrenia: A 52-week, open-label trial (EMERGENT-5). Schizophr Res 2026;288:86-94.
PMID: 41506001
|
|
|
|